Eli Lilly and Co LLY

Healthcare

Eli Lilly and Company is engaged in drug manufacturing businesses. The Company discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its diabetes, obesity and other cardiometabolic products include Basaglar, Humalog, Humulin, Jardiance, Mounjaro, Trulicity and Zepbound. Its oncology products include Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh and Taltz. Its neuroscience products include Cymbalta and Emgality. Its other products and therapies include Cialis and Forteo. The Company manufactures and distributes its products through facilities in the United States (U.S.), including Puerto Rico, and in Europe and Asia. The Company, through its subsidiary, POINT Biopharma Global Inc., is engaged in radiopharmaceutical discovery, development, and manufacturing, as well as clinical and pre-clinical radioligand therapies in development for the treatment of cancer.

NYSE:LLY - Post by User

Eli Lilly and Co

Bullboard Posts

Post by Threeclickson Jan 28, 2000 9:24am

249 Views

Post# 1289082

Lehman bros. reiterate buy

LLY was discussed this morning on Up/downgrades segment on Bloomberg. LLY: Lehman Brothers reiterating their BUY rating on the stock as well as their price target of $110/share; saying that LLY 4th qtr earnings of 61c/share are in line with expectations. Also mentioned was G and K. For more articles on LLY, G, and K https://207.235.5.146/ArticleView.ASP?articleid=37128

Bullboard Posts

This profitable gold stock is on its way up